https://www.selleckchem.com/products/vx-561.html
Parkinson disease (PD) is the second most common neurodegenerative disorder, affecting 1% of the population ≥65 years of age and with a prevalence set to double by 2030. In addition to the defining motor symptoms of PD, multiple non-motor symptoms occur; among them, cognitive impairment is common and can potentially occur at any disease stage. Cognitive decline is usually slow and insidious, but rapid in some cases. Recently, the focus has been on the early cognitive changes, where executive and visuospatial impairments are typical a
Like
Comment
Share
